Perioperative period in elderly patients with metabolic syndrome at robot-assisted radical prostatectomy
https://doi.org/10.52485/19986173_2025_2_15
Abstract
The aim of the study: to evaluate the association of metabolic syndrome (MetS) with postoperative complications and duration of treatment in elderly patients after robot-assisted radical prostatectomy.
Material and methods of the study. A retrospective, controlled, single-center observational study was conducted. 100 patients were divided into a comparison group (n = 50) and a MetS group (n = 50).
Results of the study and their discussion. The incidence of postoperative complications was statistically significantly higher in patients with MetS (p = 0,005). The duration of postoperative hospitalization was statistically significantly longer in patients with MetS.
Conclusions. In elderly patients with metabolic syndrome, robot-assisted radical prostatectomy is significantly more often accompanied by the development of postoperative adverse events and a longer duration of treatment.
About the Authors
I. R. GaleevRussian Federation
Assistant
Department of Anesthesiology and Reanimatology
450073; 3 Lenin St.; Ufa
V. V. Pogorelchuk
Russian Federation
Candidate of Medical Sciences, Associate Professor
Department of Anesthesiology, Intensive Care and Emergency Pediatrics named after Professor V.I. Gordeev
194100; 2 Litovskaya St.; Saint-Petersburg
P. I. Mironov
Russian Federation
Doctor of Medical Sciences., Professor
Department of Anesthesiology and Reanimatology
450073; 3 Lenin St.; Ufa
References
1. Lutfarakhmanov I.I., Melnikova I.A., Syrchin et al. Changes in respiratory mechanics and gas exchange in robot-assisted radical prostatectomy. Russian Journal of Anesthesiology and Reanimatology. 2020; (4): 61–68. (In Russ.) doi: 10.17116/anaesthesiology202004161.
2. Lutfarakhmanov I.I., Syrchin E.Yu., Galeev I.R., et al. Changes in central hemodynamics during robot-assisted radical prostatectomy depending on the type of anesthesia. Anesteziol Reanimatol. 2020; 6: 69–76. doi: 10.17116/anaesthesiology/anaesthesiology202006169 (In Russ).
3. Lutfarakhmanov I.I., Zdorik N.A., Lazarev S.T., et al. Comparative analysis of the safety of hypnotic component of anesthesia in robot-assisted radical prostatectomy : a review. Annals of Critical Care. 2021;3:117–125. doi: 10.21320/1818-474X-2021-3-117-125.
4. Sidse H., Frank H., Peter E., et al. Hemodynamic, renal and hormonal effects of lung protective ventilation during robot-assisted radical prostatectomy, analysis of secondary outcomes from a randomized controlled trial. BMC Anesthesiology. 2021;21:200. doi: 10.1186/s12871-021-01401-x
5. Pushkar' D.Yu., Kolontarev K.B. Robot-assisted radical prostatectomy — functional result. Part II. Pirogov Russian Journal of Surgery. 2019;(4):80-86. (In Russ.) doi: 10.17116/hirurgia201904180.
6. Cavalli L., Angehrn L., Schindler C., et al. Number of comorbidities and their impact on perioperative outcome and costs – a single centre cohort study. Swiss Medical Weekly. 2022;152:w30135 doi: 10.4414/smw.2022.w30135.
7. Recommendations of experts of Russian Scientific Society of Cardiologists on diagnosis and treatment of metabolic syndrome. Second Revision. Prakticheskaya medicina, 2010, vol. 5, no. 4, pp. 81–101. (In Russ.).
8. Aggarwal R., Ostrominski J.W., Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020. JAMA. 2024:e246892. doi: 10.1001/jama.2024.6892.
9. Tung A. Anaesthetic considerations with the metabolic syndrome. British Journal of Anaesthesia 105 (S1): i24–i33 (2010) doi: 10.1093/bja/aeq293.
Supplementary files
Review
For citations:
Galeev I.R., Pogorelchuk V.V., Mironov P.I. Perioperative period in elderly patients with metabolic syndrome at robot-assisted radical prostatectomy. Transbaikalian Medical Bulletin. 2025;(2):15-21. (In Russ.) https://doi.org/10.52485/19986173_2025_2_15